Organ transplantation--how much of the promise has been realized?
- PMID: 15937473
- DOI: 10.1038/nm1251
Organ transplantation--how much of the promise has been realized?
Abstract
Since the introduction of organ transplantation into medical practice, progress and optimism have been abundant. Improvements in immunosuppressive drugs and ancillary care have led to outstanding short-term (1--3-year) patient and graft survival rates. This success is mitigated by several problems, including poor long-term (>5-year) graft survival rates, the need for continual immunosuppressive medication and the discrepancy between the demand for organs and the supply. Developing methods to induce transplant tolerance, as a means to improve graft outcomes and eliminate the requirement for immunosuppression, and expanding the pool of organs for transplantation are the major challenges of the field.
Similar articles
-
Progress in transplantation.Ther Drug Monit. 2010 Jun;32(3):246-9. doi: 10.1097/FTD.0b013e3181dca981. Ther Drug Monit. 2010. PMID: 20418803
-
Exploiting tolerance processes in transplantation.Science. 2004 Jul 9;305(5681):209-12. doi: 10.1126/science.1099538. Science. 2004. PMID: 15247471
-
New directions for induction immunosuppression strategy in solid organ transplantation.Am J Surg. 2009 Apr;197(4):515-24. doi: 10.1016/j.amjsurg.2008.04.025. Epub 2009 Feb 27. Am J Surg. 2009. PMID: 19249743 Review.
-
Current status of renal transplantation.West J Med. 1990 Jun;152(6):687-96. West J Med. 1990. PMID: 2191502 Free PMC article. Review.
-
Pretransplant immune risk assessment.Curr Opin Organ Transplant. 2009 Dec;14(6):650-5. doi: 10.1097/MOT.0b013e32833281f8. Curr Opin Organ Transplant. 2009. PMID: 19779344 Review.
Cited by
-
Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies.Front Immunol. 2020 Jun 24;11:1326. doi: 10.3389/fimmu.2020.01326. eCollection 2020. Front Immunol. 2020. PMID: 32670292 Free PMC article. Review.
-
Vav1 GEF activity is required for T cell mediated allograft rejection.Transpl Immunol. 2012 Jun;26(4):212-9. doi: 10.1016/j.trim.2012.03.003. Epub 2012 Mar 21. Transpl Immunol. 2012. PMID: 22456277 Free PMC article.
-
Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.JAMA Dermatol. 2019 Jan 1;155(1):66-71. doi: 10.1001/jamadermatol.2018.4406. JAMA Dermatol. 2019. PMID: 30516812 Free PMC article.
-
Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells.Nat Commun. 2017 Aug 4;8(1):191. doi: 10.1038/s41467-017-00297-x. Nat Commun. 2017. PMID: 28775323 Free PMC article.
-
Reduced TCR Signaling Contributes to Impaired Th17 Responses in Tolerant Kidney Transplant Recipients.Transplantation. 2018 Jan;102(1):e10-e17. doi: 10.1097/TP.0000000000001920. Transplantation. 2018. PMID: 28902773 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical